Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors
Condition: Diffuse Large B Cell Lymphoma Interventions: Drug: Zanubrutinib; Drug: Rituximab; Drug: Cyclophosphamide; Drug: Epirubicin; Drug: Vincristine; Drug: Prednisone Sponsor: Liaoning Tumor Hospital & Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials